A recent recommendation for a two-yearly oral glucose tolerance test (OGTT) in all women with polycystic ovary syndrome is inappropriate as the test has a low yield and a positive result may have no effect on treatment, a Brisbane endocrinologist has claimed.
Associate Professor Warrick Inder, from the Princess Alexandra Hospital, said PCOS guidelines launched at the September meeting of Endocrine Society of Australia were thorough and meticulous.
However, the recommendation for a two-yearly 75 g OGTT, and annual testing for those with an additional risk factor, was not based on evidence and should not be applied universally, Professor Inder said.
The prevalence of diabetes in women younger than 30 with PCOS was less than 2%. “Therefore 98% of women with PCOS...
This site is intended for Registered Medical Practitioners.
To make the most of Endocrinology Update, you need to be logged in.